OREGA BIOTECH
Orega Biotech is a biotech company committed to the development of immunotherapeutics for the treatment of cancer. Backed by INSERM-Transfert and OCTALFA, Orega Biotech was set up in March 2010 at the initiative of its four founders bringing together scientific and business skills. The company specializes in the development of monoclonal antibodies for cancer immunotherapy. Focusing on tumor microenvironment, the company's target discovery program aims at discovering and validating novel clinically-relevant cancer targets. Orega Biotech is headquartered in Écully, France.
OREGA BIOTECH
Industry:
Biotechnology Health Care Market Research Medical Therapeutics
Founded:
2010-01-01
Address:
Écully, Rhone-Alpes, France
Country:
France
Website Url:
http://www.orega-biotech.com
Total Employee:
11+
Status:
Active
Contact:
33 4 37 49 87 20
Total Funding:
3.71 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Current Employees Featured
Gilles Alberici Founder and CEO @ Orega Biotech
Founder and CEO
2010-01-01
Armand Bensussan Founder and Scientific Advisor @ Orega Biotech
Founder and Scientific Advisor
Nathalie Bonnefoy Founder and Chief Scientific Officer @ Orega Biotech
Founder and Chief Scientific Officer
Founder
Investors List
Octalfa
Octalfa investment in Series A - Orega Biotech
Rhone-Alpes Creation
Rhone-Alpes Creation investment in Series A - Orega Biotech
Official Site Inspections
http://www.orega-biotech.com Semrush global rank: 6.17 M Semrush visits lastest month: 1.31 K
- Host name: cluster015.ovh.net
- IP address: 213.186.33.3
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
